Horak F - Search Results

1

Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study.

Horak F, Stübner P, Berger UE, Marks B, Toth J, Jäger S. Horak F, et al. J Investig Allergol Clin Immunol. 1998 May-Jun;8(3):165-71. J Investig Allergol Clin Immunol. 1998. PMID: 9684190 Clinical Trial.

2

Onset and duration of the effects of three antihistamines in current use--astemizole, loratadine and terfenadine forte--studied during prolonged, controlled allergen challenges in volunteers.

Horak F, Jäger S, Berger U. Horak F, et al. J Int Med Res. 1992 Sep;20(5):422-34. doi: 10.1177/030006059202000507. J Int Med Res. 1992. PMID: 1451923 Clinical Trial.

3

Effects of H1-receptor antagonists on nasal obstruction in atopic patients.

Horak F, Toth J, Jäger S, Berger U. Horak F, et al. Allergy. 1993 May;48(4):226-9. doi: 10.1111/j.1398-9995.1993.tb00720.x. Allergy. 1993. PMID: 8328656 Clinical Trial.

4

Quantification of conjunctival vascular reaction by digital imaging.

Horak F, Berger U, Menapace R, Schuster N. Horak F, et al. J Allergy Clin Immunol. 1996 Sep;98(3):495-500. doi: 10.1016/s0091-6749(96)70081-7. J Allergy Clin Immunol. 1996. PMID: 8828525 Clinical Trial.

5

Efficacy and tolerability of astemizole-D and Loratadine-D during prolonged, controlled allergen challenge in the Vienna Challenge Chamber.

Horak F, Jäger S, Toth J, Berger U. Horak F, et al. Arzneimittelforschung. 1996 Nov;46(11):1077-81. Arzneimittelforschung. 1996. PMID: 8955868 Clinical Trial.

6

Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients.

Horak F, Toth J, Hirschwehr R, Marks B, Stübner UP, Jäger S, Berger U, Schleinzer K, Günczler P. Horak F, et al. Allergy. 1998 Jan;53(1):68-72. doi: 10.1111/j.1398-9995.1998.tb03775.x. Allergy. 1998. PMID: 9491231 Clinical Trial.

7

Identification of common allergenic structures in mugwort and ragweed pollen.

Hirschwehr R, Heppner C, Spitzauer S, Sperr WR, Valent P, Berger U, Horak F, Jäger S, Kraft D, Valenta R. Hirschwehr R, et al. Among authors: horak f. J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):196-206. doi: 10.1016/s0091-6749(98)70384-7. J Allergy Clin Immunol. 1998. PMID: 9500752

8

Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study.

Horak F, Berger UE, Menapace R, Toth J, Stübner PU, Marks B. Horak F, et al. Arzneimittelforschung. 1998 Apr;48(4):379-84. Arzneimittelforschung. 1998. PMID: 9608880 Clinical Trial.

9

Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion.

Horak F, Toth J, Marks B, Stübner UP, Berger UE, Jäger S, Burtin B, Duby C. Horak F, et al. Allergy. 1998 Sep;53(9):849-56. doi: 10.1111/j.1398-9995.1998.tb03990.x. Allergy. 1998. PMID: 9788685 Clinical Trial.

10

Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.

Horak F, Stübner P, Zieglmeyer R, Harris AG. Horak F, et al. Allergy. 2003 Jun;58(6):481-5. doi: 10.1034/j.1398-9995.2003.00148.x. Allergy. 2003. PMID: 12757447 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

675 results

Search Page

Filters